• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二甲双胍可降低糖尿病患者突发感音神经性聋的风险:一项为期 14 年的随访研究。

Metformin decreases the risk of sudden sensorineural hearing loss in patients with diabetes mellitus: A 14-year follow-up study.

机构信息

1 Department of Otolaryngology - Head and Neck Surgery, National Defense Medical Center, Tri-Service General Hospital, Taipei.

2 Department of Medical Research, National Defense Medical Center, Tri-Service General Hospital, Taipei.

出版信息

Diab Vasc Dis Res. 2019 Jul;16(4):324-327. doi: 10.1177/1479164119826292. Epub 2019 Feb 2.

DOI:10.1177/1479164119826292
PMID:30712377
Abstract

BACKGROUND

The risk of sudden sensorineural hearing loss associated with metformin use in patients with diabetes mellitus has not been fully examined.

STUDY DESIGN

It is a retrospective matched-cohort study.

SUBJECTS AND METHODS

We examined the medical records of patients with diabetes mellitus over 18 years old in Taiwan's National Health Insurance Research Database for the period between 1 January 2000 and 31 December 2013, to establish matched cohorts (14,109 with and 42,327 without metformin use) at a ratio of 1:3 by sex, age and index year.

RESULTS

We used a Cox regression hazard model to identify risk factors of sudden sensorineural hearing loss during 14 years of follow-up, and the results indicate that a significantly lower percentage of diabetes mellitus patients with metformin use ( = 0.033) developed sudden sensorineural hearing loss compared with those without metformin use (0.21%, 29/14,109 vs 0.32%, 136/42,327). After adjustment for age and other variables [adjusted hazard ratio: 0.630 (95% confidence interval: 0.422-0.941,  = 0.024)], this study also demonstrated that metformin use appeared to reduce the risk of developing sudden sensorineural hearing loss.

CONCLUSION

This study demonstrated an association between metformin use and lower incidence of sudden sensorineural hearing loss among patients with diabetes mellitus.

摘要

背景

糖尿病患者使用二甲双胍与突发性感觉神经性听力损失的风险尚未得到充分研究。

研究设计

这是一项回顾性匹配队列研究。

受试者和方法

我们在台湾全民健康保险研究数据库中检查了 2000 年 1 月 1 日至 2013 年 12 月 31 日期间年龄超过 18 岁的糖尿病患者的病历,以建立匹配队列(14109 名使用二甲双胍和 42327 名未使用二甲双胍),性别、年龄和索引年份的比例为 1:3。

结果

我们使用 Cox 回归风险模型来确定 14 年随访期间突发性感觉神经性听力损失的危险因素,结果表明,使用二甲双胍的糖尿病患者突发性感觉神经性听力损失的比例明显较低(=0.033),而未使用二甲双胍的患者(0.21%,29/14109 与 0.32%,136/42327)。调整年龄和其他变量后[调整后的风险比:0.630(95%置信区间:0.422-0.941,=0.024)],本研究还表明,二甲双胍的使用似乎降低了突发性感觉神经性听力损失的风险。

结论

本研究表明,糖尿病患者使用二甲双胍与突发性感觉神经性听力损失的发生率较低之间存在关联。

相似文献

1
Metformin decreases the risk of sudden sensorineural hearing loss in patients with diabetes mellitus: A 14-year follow-up study.二甲双胍可降低糖尿病患者突发感音神经性聋的风险:一项为期 14 年的随访研究。
Diab Vasc Dis Res. 2019 Jul;16(4):324-327. doi: 10.1177/1479164119826292. Epub 2019 Feb 2.
2
Risk of developing sudden sensorineural hearing loss in diabetic patients: a population-based cohort study.糖尿病患者发生突发性感觉神经性听力损失的风险:基于人群的队列研究。
Otol Neurotol. 2012 Dec;33(9):1482-8. doi: 10.1097/MAO.0b013e318271397a.
3
Metabolic Syndrome Increases the Risk of Sudden Sensorineural Hearing Loss in Taiwan: A Case-Control Study.代谢综合征增加台湾突发性感音神经性听力损失的风险:一项病例对照研究。
Otolaryngol Head Neck Surg. 2015 Jul;153(1):105-11. doi: 10.1177/0194599815575713. Epub 2015 Mar 24.
4
Hypercholesterolemia is correlated with an increased risk of idiopathic sudden sensorineural hearing loss: a historical prospective cohort study.高胆固醇血症与特发性突发性感觉神经性聋的风险增加相关:一项历史性前瞻性队列研究。
Ear Hear. 2014 Mar-Apr;35(2):256-61. doi: 10.1097/AUD.0b013e3182a76637.
5
Sudden sensorineural hearing loss is correlated with an increased risk of acute myocardial infarction: a population-based cohort study.突发性聋与急性心肌梗死风险增加相关:一项基于人群的队列研究。
Laryngoscope. 2013 Sep;123(9):2254-8. doi: 10.1002/lary.23837. Epub 2013 Jul 8.
6
Recurrence of idiopathic sudden sensorineural hearing loss: a retrospective cohort study.特发性突发性感音神经性听力损失的复发:一项回顾性队列研究
Otol Neurotol. 2014 Dec;35(10):1736-41. doi: 10.1097/MAO.0000000000000630.
7
Association of sudden sensorineural hearing loss with dementia: a nationwide cohort study.突发性感觉神经性听力损失与痴呆的关联:一项全国性队列研究。
BMC Neurol. 2021 Feb 25;21(1):88. doi: 10.1186/s12883-021-02106-x.
8
Increased risk of sudden sensorineural hearing loss in patients with depressive disorders: population-based cohort study.抑郁症患者突发感音神经性听力损失风险增加:基于人群的队列研究。
J Laryngol Otol. 2016 Jan;130(1):42-9. doi: 10.1017/S0022215115002960. Epub 2015 Nov 27.
9
Association between Sudden Sensorineural Hearing Loss and Preexisting Thyroid Diseases: A Nationwide Case-Control Study in Taiwan.突发性聋与甲状腺疾病的关系:台湾一项全国性病例对照研究。
Int J Environ Res Public Health. 2020 Jan 29;17(3):834. doi: 10.3390/ijerph17030834.
10
Risk of sudden sensorineural hearing loss in patients with common preexisting sensorineural hearing impairment: a population-based study in Taiwan.患有常见的既往感音神经性听力障碍患者发生突发性感音神经性听力损失的风险:台湾一项基于人群的研究。
PLoS One. 2015 Mar 27;10(3):e0121190. doi: 10.1371/journal.pone.0121190. eCollection 2015.

引用本文的文献

1
[Clinical characteristics of sudden sensorineural hearing loss patients accompanying diabetes mellitus and efficacy analysis via propensity score matchin].突发性聋伴糖尿病患者的临床特征及倾向得分匹配法疗效分析
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Mar;39(3):207-213. doi: 10.13201/j.issn.2096-7993.2025.03.004.
2
Individual and combined effects of noise exposure and diabetes mellitus on hearing.噪声暴露与糖尿病对听力的个体及联合影响。
Noise Health. 2024;26(123):449-460. doi: 10.4103/nah.nah_71_24. Epub 2024 Dec 30.
3
Trametinib, a MEK1/2 Inhibitor, Protects Mice from Cisplatin- and Noise-Induced Hearing Loss.
曲美替尼,一种MEK1/2抑制剂,可保护小鼠免受顺铂和噪音诱导的听力损失。
Pharmaceuticals (Basel). 2024 Jun 5;17(6):735. doi: 10.3390/ph17060735.
4
FDA-Approved MEK1/2 Inhibitor, Trametinib, Protects Mice from Cisplatin and Noise-Induced Hearing Loss.美国食品药品监督管理局(FDA)批准的MEK1/2抑制剂曲美替尼可保护小鼠免受顺铂和噪声诱导的听力损失。
bioRxiv. 2024 May 21:2024.05.20.595056. doi: 10.1101/2024.05.20.595056.
5
Middle Ear Ossicular Joint Changes in Type 2 Diabetes Mellitus: A Histopathological Study.中耳听小骨关节在 2 型糖尿病中的改变:一项组织病理学研究。
Laryngoscope. 2024 Jun;134(6):2871-2878. doi: 10.1002/lary.31257. Epub 2024 Jan 4.
6
Dabrafenib protects from cisplatin-induced hearing loss in a clinically relevant mouse model.达巴非尼可预防临床相关的小鼠模型中顺铂诱导的听力损失。
JCI Insight. 2023 Dec 22;8(24):e171140. doi: 10.1172/jci.insight.171140.
7
Endothelial Dysfunction and Metabolic Disorders in Patients with Sudden Sensorineural Hearing Loss.突发性聋患者的血管内皮功能障碍与代谢紊乱
Medicina (Kaunas). 2023 Sep 26;59(10):1718. doi: 10.3390/medicina59101718.
8
Metformin Protects Against Noise-Induced Hearing Loss in Male Mice.二甲双胍可预防雄性小鼠噪声性听力损失。
Otol Neurotol. 2023 Oct 1;44(9):956-963. doi: 10.1097/MAO.0000000000004002. Epub 2023 Aug 29.
9
A Multicenter Cohort Study on the Association between Metformin Use and Hearing Loss in Patients with Type 2 Diabetes Mellitus Using a Common Data Model.一项使用通用数据模型的关于二甲双胍使用与2型糖尿病患者听力损失之间关联的多中心队列研究。
J Clin Med. 2023 Apr 27;12(9):3145. doi: 10.3390/jcm12093145.
10
Comorbidities and laboratory changes of sudden sensorineural hearing loss: a review.突发性感音神经性听力损失的合并症与实验室检查变化:综述
Front Neurol. 2023 Apr 18;14:1142459. doi: 10.3389/fneur.2023.1142459. eCollection 2023.